SS 24 - Head and Neck 2: Top-Rated Abstracts in Head & Neck Cancer

Presentations

• 03:00pm - 03:10pm PT

  A Phase II Randomized Study of Proton vs. Intensity-Modulated Radiation Therapy in the Treatment of Unilateral Head and Neck Cancer

  Speaker: Edward Dee, MD - Memorial Sloan Kettering Cancer Center, Middletown Township
• 03:00pm - 04:00pm PT

  Head and Neck 2: Top-Rated Abstracts in Head & Neck Cancer

  Speaker: Jennifer Shah, MD - University of Michigan, Ann Arbor
• 03:00pm - 04:00pm PT

  Head and Neck 2: Top-Rated Abstracts in Head & Neck Cancer

  Speaker: Matthew Ward, MD - Levine Cancer Institute, Charlotte
• 03:10pm - 03:20pm PT

  Efficacy of Compound Glutamine Enteric-Coated Capsules Combined with Thalidomide for Radiation-Induced Oral Mucositis in Oral Cancer Patients Undergoing Radiotherapy: A Multicenter, Open-Label, Randomized Controlled Trial

  Speaker: Jingyi Liu, MD - Xijing Hospital Air Force Medical University, Xi’an
• 03:20pm - 03:30pm PT

  Proton vs. Photon for Nasopharyngeal Carcinoma: Toxicity and Survival in a Phase 2 Randomized Study

  Speaker: Lin Kong, MD - Fudan University Shanghai Cancer Center, Shanghai
• 03:30pm - 03:40pm PT

  Phase I Dose Escalation/Dose Expansion Trial of NBTXR3/SBRT in Combination with Nivolumab or Pembrolizumab for the Treatment of anti-PD-1 Naïve or Resistant Patients with Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma

  Speaker: Colette Shen, MD, PhD - University of North Carolina School of Medicine & Lineberger Comprehensive Cancer Center, Chapel Hill
• 03:40pm - 03:50pm PT

  Discussant

  Speaker: Annie Chan, MD, FASTRO - Massachusetts General Hospital, Boston